BC insider buy: Director adds 1,132 shares at $66.11, Form 4

Rhea-AI Filing Summary

Brunswick Corp (BC) reported an insider transaction on Form 4. Director Joseph W. McClanathan acquired 1,132 shares of common stock on 10/31/2025 at $66.11 per share (Transaction Code A). Following the transaction, he beneficially owns 25,842 shares. The filing notes that 499 of these shares are deferred and will be distributed in installments after he ceases being a director, and that holdings include 135 shares acquired via dividend reinvestment in September 2025.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCCLANATHAN JOSEPH W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,132	$66.11	$75K

Holdings After Transaction: Common Stock — 25,842 shares (Direct)

Footnotes (1)

1. 499 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 135 shares acquired pursuant to dividend reinvestment in September 2025.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCCLANATHAN JOSEPH W

(Last) (First) (Middle)

C/O BRUNSWICK CORPORATION

26125 N RIVERWOODS BLVD SUITE 500

(Street)

METTAWA IL 60045-3420

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/31/2025		A		1,132(1)	A	$66.11	25,842(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 499 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

2. Beneficial holdings include 135 shares acquired pursuant to dividend reinvestment in September 2025.

Remarks:

	By: Power of Attorney For: /s/ Joseph W. McClanathan	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Brunswick (BC) disclose?

A director acquired 1,132 shares of common stock on 10/31/2025 at $66.11 per share (Code A).

Who is the reporting person in the BC Form 4?

The reporting person is Director Joseph W. McClanathan.

How many shares does the director own after the transaction?

Post-transaction beneficial ownership is 25,842 shares.

Were any shares subject to deferral or special terms?

499 shares are deferred and will be distributed in predetermined installments after he ceases being a director.

Does the filing mention dividend reinvestment?

Yes. Beneficial holdings include 135 shares acquired via dividend reinvestment in September 2025.

What was the transaction price per share?

The reported price was $66.11 per share.